Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.
The WHO classification of soft tissue and bone tumours presented in this book reflects the view of the WHO Classification of Tumours Editorial Board that convened at the International Agency for Research on Cancer, Lyon, France, 6-8 May 2019. -- page [iii]
c.1 BC Cancer Agency VAN Library | Available |
c.2 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | On Loan, due Tuesday, May 14, 2024 |
c.1 BC Cancer Agency KEL Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
This book reviews the latest techniques for diagnostics and treatments specific to bone and soft tissue tumors. It focuses on imaging and classification of the bone and soft tissue tumors and how histology and cytogenetic aspects can be used to identify tumors. Each chapter focuses on a specific ty…
Contents:; Clinical presentation of bone tumors -- Clinical presentation of soft-tissue tumors -- Musculoskeletal radiology and imaging of tumors -- Biopsy -- Tumor-mimicking lesions : tumor simulators -- Latent bone lesions in children -- Active and aggressive benign bone lesions in children and y…
c.1 BC Cancer Agency VAN Library | Available |
"This book presents the clinical scope of cancer immunotherapeutic agents for solid tumors and Hematologic malignancies, elaborates on the scientific details of their modes of action, and presents the impact of these agents on oncology, patients and the broader healthcare system. At present, cancer…
c.1 BC Cancer Agency VAN Library | Available |
"Clinical and preclinical exploration of gene and cellular immunotherapy have seen rapid growth and interest with the development and approval of five Chimeric Antigen Receptor T-cell (CAR-T) products for lymphoma and myeloma and one Bispecific T-Cell Engager (BiTE) for acute lymphoblastic leukemia…
Contents:; Chapter 1 -- Considerations of Novel Diagnostic and Therapeutic Approaches to Metastatic Triple-Negative Breast Cancer -- Correlations of Germline BRCA Mutations with TNBC ? Taking Advantage of ?Vulnerable? Tumors -- Mutations in BRCA Genes and PD-L1?expression on the Immune Cells - As I…
Contents:; Introduction -- When to refer a patient for CAR-T cell therapy -- Optimizing the apheresis product -- CAR T cells: cell processing laboratory considerations -- Peri-CAR-T cell management -- Management of cytokine release syndrome -- Special considerations for ICU management of patients r…
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |